×
About 2,690 results

ALLMedicine™ Subdural Hematoma Center

Research & Reviews  982 results

The "Bright Falx" Sign-Midline Embolic Penetration Is Associated With Faster Resolution...
https://doi.org/10.1227/neu.0000000000002038
Neurosurgery Samarage HM, Kim WJ et. al.

May 14th, 2022 - Chronic subdural hematomas (CSDHs) are common in the elderly population and patients taking antiplatelet/anticoagulation medications. Middle meningeal artery (MMA) embolization has become an adjunctive treatment to observation and surgery. Despite...

Grading Scale for Embolization of Middle Meningeal Artery for Chronic Subdural Hematoma.
https://doi.org/10.1017/cjn.2021.503
The Canadian Journal of Neurological Sciences. Le Journal... Shankar J, Kaderali Z

May 12th, 2022 - Grading Scale for Embolization of Middle Meningeal Artery for Chronic Subdural Hematoma.|2022|Shankar J,Kaderali Z,|

Closed Head Injury
https://emedicine.medscape.com/article/251834-print

May 4th, 2022 - Practice Essentials In the United States, closed head injury, or traumatic brain injury (TBI), has an annual incidence of approximately 500 in 100,000. Around 80% of all TBI cases are categorized as mild head injuries.[1] Approximately 15% of thes...

Supraorbital keyhole craniotomy in pediatric neurosurgery: a systematic review of clini...
https://doi.org/10.1016/j.wneu.2022.04.094
World Neurosurgery; Yang CY, Faung B et. al.

May 2nd, 2022 - The supraorbital keyhole craniotomy is a minimally invasive approach used to access the parasellar region with advantages of decreased cortical exposure, simple closure, and a decreased risk of postoperative cerebrospinal fluid (CSF) leak. The inc...

Differences in Presentation, Radiological Features, and Outcomes in Traumatic Versus Sp...
https://doi.org/10.1016/j.wneu.2022.04.083
World Neurosurgery; Khaki D, Ljungqvist J et. al.

Apr 30th, 2022 - Spontaneous acute subdural hematoma (sASDH) is a rare neurosurgical condition, with the literature mainly consisting of case reports. In the present study, we compared sASDH with traumatic ASDH (tASDH) to determine the differences in presentation,...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  37 results

Swedish Trial on Embolization of Middle Meningeal Artery Versus Surgical Evacuation in Chronic Subdural Hematoma
https://clinicaltrials.gov/ct2/show/NCT05267184

Apr 29th, 2022 - Introduction: Chronic subdural hematoma (CSDH) is one of the most common neurosurgical disorders and the incidence is rising. The mainstay of treatment is neurosurgical hematoma evacuation followed by postoperative drainage but recurrence and reop...

Targeting Spreading Depolarization After Chronic Subdural Hematoma Surgery (TASD)
https://clinicaltrials.gov/ct2/show/NCT04966546

Apr 22nd, 2022 - Objectives 1.1. Assess risk factors for SD and seizures 1.2. Compare clinical outcomes between patients with SD and without 1.3. Obtain preliminary data on safety and efficacy of Memantine in subjects with SD 1.4. Assess early temporal relationshi...

Preventing Recurrences of Chronic Subdural Hematoma in Adult Patients by Middle Meningeal Artery Embolization
https://clinicaltrials.gov/ct2/show/NCT05327933

Apr 14th, 2022 - Patients with a chronic subdural hematoma (cSDH), that is, a blood accumulation between two meninges developing over a long period of time, often have recurrent bleedings after an initial operation. The study aims to show that additional surgery r...

Monitored Anesthesia Care: Dexmedetomidine-Ketamine Versus Dexmedetomidine- Propofol For Chronic Subdural Hematoma
https://clinicaltrials.gov/ct2/show/NCT04621526

Mar 31st, 2022 - Null hypothesis (H0): There are no differences between the effects of dexmedetomidine- ketamine and dexmedetomidine- propofol combination for monitored anesthesia care during burr-hole surgery for chronic subdural hematoma evacuation. Alternative ...

Exhaustive Drainage Versus Fixed-time Drainage for Chronic Subdural Hematoma After One-burr Hole Craniostomy
https://clinicaltrials.gov/ct2/show/NCT04573387

Mar 14th, 2022 - Chronic subdural hematomas (CSDHs) are one of the most common neurosurgical conditions. The goal of surgery is to alleviate symptoms and minimize the risk of symptomatic recurrences. The standard surgical technique includes burr-hole craniostomy, ...

see more →

News  53 results

A New Era of Precision Medicine Takes Shape in Prostate Cancer
https://www.onclive.com/view/a-new-era-of-precision-medicine-takes-shape-in-prostate-cancer

Oct 26th, 2021 - Prostate cancer is a highly hetero-geneous disease, with individual tumor cells having distinct genomic and pheno-typic characteristics, resulting in a great deal of variability in patients’ disease course. Although some pros-tate cancers are slow...

MD Charged With Manslaughter Now Faces Malpractice Suit for Performing the Wrong Brain Surgery
https://www.medscape.com/viewarticle/952438

Jun 4th, 2021 - An Alabama neurosurgeon who was charged with manslaughter in the death of a third-year medical student is now facing a malpractice suit alleging he performed the wrong brain surgery. The brain surgery patient's widow, Christine Metzger, is suing J...

5 Updates in Neurology
https://www.medscape.com/viewarticle/943659

Jan 20th, 2021 - This transcript has been edited for clarity. Dear colleagues, I'm Christoph Diener from the University of Duisburg-Essen in Germany, here to tell you about five interesting neurology studies published in December 2020. The first study of interest ...

Dexamethasone Harmful in Chronic Subdural Hematoma
https://www.medscape.com/viewarticle/943701

Jan 7th, 2021 - A commonly used treatment for chronic subdural hematoma appears to be doing more harm than good, a new randomized trial has shown. The results show that patients given the steroid dexamethasone had worse functional outcomes at 6 months than those ...

Extended Phase III Data Illuminates Ibrutinib Survival Benefit in CLL
https://www.onclive.com/view/extended-phase-iii-data-illuminates-ibrutinib-survival-benefit-in-cll

Dec 20th, 2020 - Jennifer R. Brown, MD, PhD Extended follow-up data continue to demonstrate the efficacy and tolerability of ibrutinib (Imbruvica) in previously treated patients with chronic lymphocytic leukemia (CLL), including those with high-risk gene mutation...

see more →

Patient Education  1 results see all →